Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...

The FDA has approved its first at-home, nondrug therapy for depression, with a wearable brain stimulation headset developed by Flow Neuroscience. The agency issued a green light that covers the device ...

Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...

The collection of high-quality genomic DNA remains a major barrier in pediatric and neurodevelopmental research, particularly ...

The array station features an upgraded Caliper Sciclone liquid-handling workstation and an on-board Twister® II plate handler for fast start-up and easy operation.